These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21590687)

  • 1. Perifosine-induced inhibition of Akt attenuates brain-derived neurotrophic factor/TrkB-induced chemoresistance in neuroblastoma in vivo.
    Li Z; Oh DY; Nakamura K; Thiele CJ
    Cancer; 2011 Dec; 117(23):5412-22. PubMed ID: 21590687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway.
    Jaboin J; Kim CJ; Kaplan DR; Thiele CJ
    Cancer Res; 2002 Nov; 62(22):6756-63. PubMed ID: 12438277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trk inhibitor attenuates the BDNF/TrkB-induced protection of neuroblastoma cells from etoposide in vitro and in vivo.
    Li Z; Zhang Y; Tong Y; Tong J; Thiele CJ
    Cancer Biol Ther; 2015; 16(3):477-83. PubMed ID: 25700942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo inhibition of neuroblastoma tumor cell growth by AKT inhibitor perifosine.
    Li Z; Tan F; Liewehr DJ; Steinberg SM; Thiele CJ
    J Natl Cancer Inst; 2010 Jun; 102(11):758-70. PubMed ID: 20463309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of glycogen synthase kinase-3beta contributes to brain-derived neutrophic factor/TrkB-induced resistance to chemotherapy in neuroblastoma cells.
    Li Z; Tan F; Thiele CJ
    Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3113-21. PubMed ID: 18089706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53/PUMA are potential targets that mediate the protection of brain-derived neurotrophic factor (BDNF)/TrkB from etoposide-induced cell death in neuroblastoma (NB).
    Hua Z; Zhan Y; Zhang S; Dong Y; Jiang M; Tan F; Liu Z; Thiele CJ; Li Z
    Apoptosis; 2018 Aug; 23(7-8):408-419. PubMed ID: 29959561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death.
    Li Z; Jaboin J; Dennis PA; Thiele CJ
    Cancer Res; 2005 Mar; 65(6):2070-5. PubMed ID: 15781614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death.
    Li Z; Zhang J; Liu Z; Woo CW; Thiele CJ
    Cell Death Differ; 2007 Feb; 14(2):318-26. PubMed ID: 16778834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to chemotherapy mediated by TrkB in neuroblastomas.
    Ho R; Eggert A; Hishiki T; Minturn JE; Ikegaki N; Foster P; Camoratto AM; Evans AE; Brodeur GM
    Cancer Res; 2002 Nov; 62(22):6462-6. PubMed ID: 12438236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI3K and MAPK pathways mediate the BDNF/TrkB-increased metastasis in neuroblastoma.
    Hua Z; Gu X; Dong Y; Tan F; Liu Z; Thiele CJ; Li Z
    Tumour Biol; 2016 Oct; 37(12):16227-36. PubMed ID: 27752996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of tyrosine kinase receptor B and brain-derived neurotrophic factor on chemoresistance in neuroblastoma].
    Li AM; Zhang JH; Zhang JH; Zhang KR; Rong DJ
    Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):535-9. PubMed ID: 17044982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways.
    Nyåkern M; Cappellini A; Mantovani I; Martelli AM
    Mol Cancer Ther; 2006 Jun; 5(6):1559-70. PubMed ID: 16818515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Akt to increase the sensitivity of neuroblastoma to chemotherapy: lessons learned from the brain-derived neurotrophic factor/TrkB signal transduction pathway.
    Li Z; Thiele CJ
    Expert Opin Ther Targets; 2007 Dec; 11(12):1611-21. PubMed ID: 18020981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of an allosteric Akt Inhibitor MK-2206 with etoposide or rapamycin enhances the antitumor growth effect in neuroblastoma.
    Li Z; Yan S; Attayan N; Ramalingam S; Thiele CJ
    Clin Cancer Res; 2012 Jul; 18(13):3603-15. PubMed ID: 22550167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts.
    Croucher JL; Iyer R; Li N; Molteni V; Loren J; Gordon WP; Tuntland T; Liu B; Brodeur GM
    Cancer Chemother Pharmacol; 2015 Jan; 75(1):131-41. PubMed ID: 25394774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of TrkB-BDNF signal pathway on synthesis and secretion of vascular endothelial growth factor in human neuroblastoma cells].
    Li KX; Li AM; Zhang JH
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Mar; 13(3):240-3. PubMed ID: 21426646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blocking TrkB-BDNF signal pathway decreases the livability of neuroblastoma cells].
    Zhang JH; Li AM; Chen S; Tong HX; Zhang KR; Zhang JH
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):47-50. PubMed ID: 18289471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells.
    Papa V; Tazzari PL; Chiarini F; Cappellini A; Ricci F; Billi AM; Evangelisti C; Ottaviani E; Martinelli G; Testoni N; McCubrey JA; Martelli AM
    Leukemia; 2008 Jan; 22(1):147-60. PubMed ID: 17928881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo.
    Momota H; Nerio E; Holland EC
    Cancer Res; 2005 Aug; 65(16):7429-35. PubMed ID: 16103096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.
    Czarnecka M; Trinh E; Lu C; Kuan-Celarier A; Galli S; Hong SH; Tilan JU; Talisman N; Izycka-Swieszewska E; Tsuei J; Yang C; Martin S; Horton M; Christian D; Everhart L; Maheswaran I; Kitlinska J
    Oncogene; 2015 Jun; 34(24):3131-43. PubMed ID: 25132261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.